Patent · US Active

Monitoring myocardial infarction and its treatment

US8771961B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Georg Hess · Mainz, DE
Andrea Horsch · Luzern, CH
Dietmar Zdunek · Tutzing, DE

Key dates

Filing date	Mar 29, 2010
Grant date	Jul 8, 2014
Priority date	—
Expiry date	Dec 7, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is a method of determining which medication is to be applied in a remodeling process of a subject after a myocardial infarction, the method comprising determining an amount of a natriuretic peptide, a cardiac troponin, and an inflammatory marker in a sample from the subject and initiating a remodeling in the subject, wherein the medication to be applied in the remodeling is selected according to the level of the peptides determined. Also disclosed is a method of monitoring the remodeling, wherein further steps include again determining an amount of the natriuretic peptide, the cardiac troponin, and the inflammatory marker in a sample from the subject, calculating the difference between the values from the first and second measurements, and assessing remodeling success from the data obtained.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.